Navigation Links
Clarient to Commercialize Novel Breast Cancer Profile
Date:1/9/2008

t our strong cancer-focused brand, support and loyalty among community pathologists and our unique, Internet-based PATHSiTE(TM) delivery system will drive market acceptance for this exciting test."

The new breast cancer profile has undergone rigorous validation. The results to date show excellent accuracy and substantial out-performance of standard treatment guidelines. As preparations are made for full market launch in 2008, the companies will continue to generate clinical data designed to further expand the established indications and to comply with future regulatory requirements. The companies believe that Clarient's Insight Dx Breast Cancer Profile fits the description of a lab-developed test according to the current regulatory guidelines. Should the FDA adopt proposed guidance to regulate certain lab-developed tests, the companies intend to submit the required documentation for clearance within the timeframe provided.

"Clarient currently performs approximately 20 percent of all breast cancer prognostic work-ups in the U.S.," Andrews continued. "We are extremely proud of the brand we have developed in such a short period in the area of breast cancer, and the availability of this high-value test could improve patient care and decrease the economic burden on the healthcare system."

About Prediction Sciences

Based in La Jolla, California, Prediction Sciences develops high-value molecular diagnostics and assays for disease detection, prognosis, and treatment outcome prediction under their trademarked brand names, RapidResponse(TM) and GeneRx(TM). Prediction Sciences has a deep diagnostics pipeline, with lead candidates that address critical unmet clinical needs in oncology and stroke. Prediction Sciences is committed to improving the safety and efficacy of disease treatments, and their diagnostic tests are making personalized medicine a reality. http://www.predict.net

About Clarien
'/>"/>

SOURCE Clarient
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
3. Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan
4. Affymax(R) and Takeda Recognized for Innovative Global Agreement to Develop and Commercialize Hematide(TM) for Anemia
5. Rib-X Pharmaceuticals Initiates Two Phase 2 Studies for Novel Antibiotic Compound RX-1741
6. New Drug Application for Tolvaptan, Otsukas Investigational Novel Oral Treatment for Worsening Heart Failure and Hyponatremia, Accepted by the U.S. Food and Drug Administration
7. Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-Cancer Drugs
8. Bystolic(TM), a Novel Beta Blocker, is Now Approved by the FDA for the Treatment of Hypertension
9. Oxford Genome Sciences and Amgen to Jointly Discover Novel Therapeutic Antibodies in Cancer
10. First European Patient Treated in CABERNET Trial With Novel Treatment for Wet AMD
11. DOE JGI plumbs termite guts to yield novel enzymes for better biofuel production

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2009)...,, TORONTO, Nov. 6 /PRNewswire-FirstCall/ - Mic...day that it has re-filed the Form 52-109F1 Certifi...ief Executive Officer and James Long, the Chief Fi...ed January 12, 2009 in connection with the annual ...ptember 30, 2008. ,, The Company initially file...
(Date:11/6/2009)...,, QUINCY, Mass., Nov. 6 Myrian...biotech developer and manufacturer of renewable b...preferred technology provider Uhde GmbH, one of th... "Uhde"), announced an alliance for the engineerin...,s biobased Succinic Acid plants based on renewabl...
(Date:11/6/2009)...,, SPRING VALLEY, Calif., Nov. 6 /PRNewswire/ -...n awarded a Small Business Innovative Research (SB...arch and Material command. Under terms of the agre...agents (ASRs) for the diagnosis of Dengue virus. ... that represents a major threat to military forces...
(Date:11/6/2009)... The agenda for Arrowhead...onference, which is set to take place on February ...t this three day conference we will highlight key ... speakers to share their experiences. , ... 2009 -- The agenda for Arrowhead’s 2010 Pe...
Breaking Biology Technology:Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 2Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3
... This release is available in French . , An N...laid the groundwork for a lithium battery that can... of conventional lithium ion batteries. , The re...dent David Xiulei Ji and postdoctoral fellow Kyu T...electrochemical performance for a lithium-sulphur ...
... SEATTLE, May 18 /PRNewswire-FirstCall/ - Oncothyr...ced the presentation of data demonstrating the eff...l model of pulmonary fibrosis. The data were prese...ociate Professor, Pulmonary Medicine, Children,s H...merican Thoracic Society International Conference ...
... Non-Profit Biotech Calls on the Entire ALS Commun...ay Events , , CAMBRIDGE, Mass., May 18 The ALS ...its BBQ For ALS Awareness , is a national initiat...anding of ALS (amyotrophic lateral sclerosis), oth...h its goal, the campaign brings together three und...
Other Biology Technology:Canadian research team reports major breakthrough in lithium battery technology 2Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis 2Oncothyreon's PX-866 is effective in preclinical model of pulmonary fibrosis 3Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 2Campaign to Increase the Awareness and Understanding of Lou Gehrig's Disease Reaches 22 U.S. States 3
(Date:11/4/2009)... DigitalPersona, Inc., a leader in ... today announced that WAND Corporation, a leading ...-service restaurants, has integrated DigitalPerson...S solutions. WAND,s quick-service customers can no...untability and deter unauthorized manager override...
(Date:11/4/2009)...re/ -- What,s the cost of saving a teenage life? W...ing from prescription medication abuse, there,s no... may be unaware that the lock-boxes they,ve instal...g timebomb of prescription drugs. That,s why MEDNE...l supplies, has formed an exclusive partnership wi...
(Date:11/4/2009)...e-FirstCall/ -- BIO-key International, Inc. (OTC B...metric identification software is showcasing donor...onference being held at the New Orleans Convention...ide hands-on product demonstrations of its state-o... Also, at 5 PM on Monday, October 26, Peter Lux, m...
Breaking Biology News(10 mins):WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 2WAND Point-of-Sale Solutions Integrate U.are.U(R) Fingerprint Biometrics From DigitalPersona for Quick-Service Restaurants 3MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 2MEDNET Launches MedSafe to Prevent Teenage Prescription Drug Abuse 3BIO-key(R) International Exhibiting at AABB TXPO 2Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 1Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 2Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 3Ohio Law Firm Warns of Birth Control Pill YAZ Yasmin Side Effects Lawsuits 54279 4Mysterious charge transport in self assembled monolayer transistors unraveled 13515 1Mysterious charge transport in self assembled monolayer transistors unraveled 13515 2Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 1Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 2Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 3Emdeon Inc Prices Initial Public Offering of Class A Common Stock at 2415 50 Per Share 54275 4
...ncestral line of parasitic bacteria, scientists ca...o revealed where you lived or who you spent time w...ow to look. , Stanford researchers with collabora...dation for opening such a window to the past using...ue uses genomic data to examine metabolic networks...
...cal model could be used to predict an individual,s...hildren,s Hospital Informatics Program (CHIP). Usi... the researchers showed that their predictive mode...ardioembolic stroke -- the most common form of str...reported in the March issue of Stroke . , "For c...
... warning signs of climate change in the upper atmo...e 2009 Tyler Prize for Environmental Achievement. ... and gold medals, will go to Richard Alley, profes...eerabhadran (Ram) Ramanathan, professor of atmosph...on of Oceanography at the University of California...
Other Biology News:Reversing ecology reveals ancient environments 2Predicting risk of stroke from one's genetic blueprint 2Winners of Tyler environmental prize announced 2
...Linear Ion Trap Time of Flight Mass Analyzer for s...power., Specifications:, * MS mode measurement r...range: 150 - 4000 m/z, * Resolution: 14,000 (1400 ...eference, * Dynamic range: 4 orders of magnitude ...
...lay Vector is specifically designed to target and ...charomyces cerevisiae. Displayed proteins can be a...r putative ligands. pYD1 uses the a-agglutinin yea..., Aga1 and Aga2, to display recombinant protein on...
...is a pleiotropic cytokine produced by activated T ...nhibits the growth of some tumour and normal cell ...osis sarcoma cell proliferation, cytokine release ... receptor expression on hepatoma cells. Mouse OSM ...
Mouse Anti-Human BTAF1 Polyclonal Antibody, Unconjugated from Novus Biologicals
Biology Products: